Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2015 1
2018 2
2019 2
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Results by year
Filters applied: . Clear all
Page 1
Ketamine normalizes subgenual cingulate cortex hyper-activity in depression.
Morris LS, Costi S, Tan A, Stern ER, Charney DS, Murrough JW. Morris LS, et al. Among authors: costi s. Neuropsychopharmacology. 2020 May;45(6):975-981. doi: 10.1038/s41386-019-0591-5. Epub 2020 Jan 2. Neuropsychopharmacology. 2020. PMID: 31896116
Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial.
Costi S, Soleimani L, Glasgow A, Brallier J, Spivack J, Schwartz J, Levitch CF, Richards S, Hoch M, Wade E, Welch A, Collins KA, Feder A, Iosifescu DV, Charney DS, Murrough JW. Costi S, et al. Neuropsychopharmacology. 2019 Sep;44(10):1812-1819. doi: 10.1038/s41386-019-0365-0. Epub 2019 Mar 11. Neuropsychopharmacology. 2019. PMID: 30858518 Free PMC article. Clinical Trial.
Ultra-high field MRI reveals mood-related circuit disturbances in depression: a comparison between 3-Tesla and 7-Tesla.
Morris LS, Kundu P, Costi S, Collins A, Schneider M, Verma G, Balchandani P, Murrough JW. Morris LS, et al. Among authors: costi s. Transl Psychiatry. 2019 Feb 15;9(1):94. doi: 10.1038/s41398-019-0425-6. Transl Psychiatry. 2019. PMID: 30770788 Free PMC article.
Effects of the KCNQ channel opener ezogabine on functional connectivity of the ventral striatum and clinical symptoms in patients with major depressive disorder.
Tan A, Costi S, Morris LS, Van Dam NT, Kautz M, Whitton AE, Friedman AK, Collins KA, Ahle G, Chadha N, Do B, Pizzagalli DA, Iosifescu DV, Nestler EJ, Han MH, Murrough JW. Tan A, et al. Among authors: costi s. Mol Psychiatry. 2020 Jun;25(6):1323-1333. doi: 10.1038/s41380-018-0283-2. Epub 2018 Nov 1. Mol Psychiatry. 2020. PMID: 30385872 Free PMC article.
A Randomized Dose-Ranging Study of Neuropeptide Y in Patients with Posttraumatic Stress Disorder.
Sayed S, Van Dam NT, Horn SR, Kautz MM, Parides M, Costi S, Collins KA, Iacoviello B, Iosifescu DV, Mathé AA, Southwick SM, Feder A, Charney DS, Murrough JW. Sayed S, et al. Among authors: costi s. Int J Neuropsychopharmacol. 2018 Jan 1;21(1):3-11. doi: 10.1093/ijnp/pyx109. Int J Neuropsychopharmacol. 2018. PMID: 29186416 Free PMC article. Clinical Trial.
Current Status of Ketamine and Related Therapies for Mood and Anxiety Disorders.
Costi S, Van Dam NT, Murrough JW. Costi S, et al. Curr Behav Neurosci Rep. 2015 Dec;2(4):216-225. doi: 10.1007/s40473-015-0052-3. Epub 2015 Oct 1. Curr Behav Neurosci Rep. 2015. PMID: 26783510 Free PMC article.
Partial androgen deficiency, depression, and testosterone supplementation in aging men.
Amore M, Innamorati M, Costi S, Sher L, Girardi P, Pompili M. Amore M, et al. Among authors: costi s. Int J Endocrinol. 2012;2012:280724. doi: 10.1155/2012/280724. Epub 2012 Jun 7. Int J Endocrinol. 2012. PMID: 22719760 Free PMC article.